Jazz Pharmaceuticals Symposium

Laying the Foundations for Long Term Remission in High-Risk AML*

*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)

Thursday 29th October, 12:30 – 13:00

2 minsWelcome and IntroductionProf Alessandro Isidori, Italy
24 minsLaying the Foundation for Long Term Remission in High-Risk AML*Dr Donal McLornan, UK
4 minsSummary and CloseProf Alessandro Isidor, Italy

This symposium is funded and organised by Jazz Pharmaceuticals.
This symposium will contain promotional content and prescribing information will be shown at the end of each presentation and at the end of the symposium.

 This symposium is intended for healthcare professionals only.

Adverse events should be reported. Healthcare professionals are asked to report any suspected adverse events via their national reporting system.

Adverse events should also be reported to Jazz Pharmaceuticals at AEreporting@jazzpharma.com or by fax to +44 (0) 1865 598765




EUROLEUK will be broadcast Central European Time (CET)

Approximately one week before the Congress, all registered delegates will receive an invitation with a personal link to set their profile and enter the virtual Congress platform. Your personal link will only be valid until the end of the Congress. In order to view the Congress lectures and panel discussions, delegates must enter the virtual Congress platform and set their profile before the end of the Congress.

For assistance entering the virtual platform, please send an email to: info@bioevents-congress.com